SI-BONE, Inc.
Nasdaq SIBN · Santa Clara, CA
Works in Metabolic & endocrine · Musculoskeletal
SI-BONE, Inc. is a clinical trial sponsor based in Santa Clara, CA, listed as Nasdaq SIBN. It has 5 active clinical trials with 1,550 planned participants, in Metabolic & endocrine and Musculoskeletal. Since 2021 it has completed 2 trials and stopped 1 early.
Trial track record · since 2021
Financials · Nasdaq SIBN
Pipeline · 5 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about SI-BONE, Inc
SI-BONE, Inc is lead sponsor of 5 active clinical trials on ClinicalTrials.gov, with 1,550 planned participants, in Metabolic & endocrine, Musculoskeletal. Since 2021 it has completed 2 trials and stopped 1 early.
SI-BONE, Inc is based in Santa Clara, CA and is listed as Nasdaq SIBN. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with SI-BONE, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-08-24.
Approve Suite is not affiliated with SI-BONE, Inc.. Informational only.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.